November 05, 2020 Aprea Therapeutics Reports Third Quarter 2020 Financial Results and Provides Update on Business Operations
November 04, 2020 Oncopeptides Announces that New Data for Melflufen is Accepted for Presentation at the Annual American Society of Hematology Meeting
November 04, 2020 Correction notice of press release – Q3 2020 Interim Report – ZUBSOLV® guiding 2020
November 03, 2020 GenSight Biologics reports validation of LUMEVOQ® Marketing Authorisation Application (MAA) by European Medicines Agency